ESC 365 - Activation of invariant natural killer T cells for heart failure therapy.

ESC Premium Access

Activation of invariant natural killer T cells for heart failure therapy.

Session: Translating Basic Science Discoveries into Clinical Practice

Topic: Basic Science, Other

Speaker: Doctor M. Ikeda (Fukuoka, JP)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Masataka Ikeda

Kyushu University Faculty of Medical Sciences, Fukuoka (Japan)

1 presentation

0 follower

3 more presentations in this session

Dietary spermidine: a story of cardioprotection and longevity.

Speaker: Doctor M. Abdellatif (Paris, FR)

Mutant KCNJ3 and KCNJ5 potassium channels as novel molecular targets in bradyarrhythmias and atrial fibrillation.

Speaker: Doctor N. Yamada (Suita, JP)

A novel anti-arrhythmic drug: the TASK-1 channel tale.

Speaker: Professor C. Schmidt (Heidelberg, DE)

Access the full session

Translating Basic Science Discoveries into Clinical Practice

Speakers: Doctor M. Ikeda, Doctor M. Abdellatif, Doctor N. Yamada, Professor C. Schmidt

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by